Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Receptor-mediated Endocytosis01:38

Receptor-mediated Endocytosis

Overview
Receptor-mediated Endocytosis01:20

Receptor-mediated Endocytosis

Receptor-mediated endocytosis is when bulk amounts of specific molecules are imported into a cell after binding to cell surface receptors. The molecules bound to these receptors are taken into the cell through inward folding of the cell surface membrane, which is eventually pinched off into a vesicle within the cell. Structural proteins, such as clathrin, coat the budding vesicle.
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
The Two-State Receptor Model01:29

The Two-State Receptor Model

The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vasoreactivity Test With Nitrate-Hydralazine by Linking Gas Exchange and Hemodynamics in PH-HFpEF.

Journal of cardiac failure - intersections·2026
Same author

SWI/SNF alterations define a subgroup with poorer outcome among patients with aggressive forms of adult T-cell leukemia/lymphoma.

Haematologica·2026
Same author

Strand-specific detection of cell-associated sense and antisense HIV-1 RNAs in splenocytes and PBMC from PLWH.

Retrovirology·2025
Same author

Waldenström's macroglobulinemia: The LYSA pragmatic guidelines.

European journal of cancer (Oxford, England : 1990)·2025
Same author

Bortezomib, Rituximab and Dexamethasone Regimen (BDR) in Waldenström Macroglobulinaemia: A Retrospective Real-World Analysis.

EJHaem·2025
Same author

Venetoclax-proteasome inhibitor-dexamethasone for unfit patients with blastic plasmacytoid dendritic cell neoplasm.

Blood advances·2024

Related Experiment Video

Updated: Jun 6, 2026

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation
12:09

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation

Published on: February 28, 2019

Current concepts regarding the HTLV-1 receptor complex.

David Ghez1, Yves Lepelletier, Kathryn S Jones

  • 1CNRS UMR8147, Universite Rene Descartes, Paris 5, 161 Rue de Sèvres, 75743 Paris Cedex 15, France. david.ghez@igr.fr

Retrovirology
|December 1, 2010
PubMed
Summary

Human T lymphotropic Virus type 1 (HTLV-1) entry involves Glucose Transporter 1, Neuropilin-1, and Heparan Sulfate Proteoglycans. This study proposes a model for the HTLV-1 receptor complex to clarify its role in infection.

More Related Videos

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens
09:53

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens

Published on: February 6, 2017

Imaging of HIV-1 Envelope-induced Virological Synapse and Signaling on Synthetic Lipid Bilayers
11:45

Imaging of HIV-1 Envelope-induced Virological Synapse and Signaling on Synthetic Lipid Bilayers

Published on: March 8, 2012

Related Experiment Videos

Last Updated: Jun 6, 2026

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation
12:09

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation

Published on: February 28, 2019

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens
09:53

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens

Published on: February 6, 2017

Imaging of HIV-1 Envelope-induced Virological Synapse and Signaling on Synthetic Lipid Bilayers
11:45

Imaging of HIV-1 Envelope-induced Virological Synapse and Signaling on Synthetic Lipid Bilayers

Published on: March 8, 2012

Area of Science:

  • Virology
  • Molecular Biology
  • Cell Biology

Background:

  • The receptor for Human T lymphotropic Virus type 1 (HTLV-1) was unknown for 20 years.
  • Recent studies identified Glucose Transporter 1 (GLUT1), Neuropilin-1 (NPN-1), and Heparan Sulfate Proteoglycans (HSPGs) as key molecules in HTLV-1 binding and entry.

Purpose of the Study:

  • To elucidate the precise roles of GLUT1, NPN-1, and HSPGs in HTLV-1 viral entry.
  • To propose a comprehensive model of the HTLV-1 receptor complex based on current data.
  • To discuss the implications of this receptor complex model for HTLV-1 infection.

Main Methods:

  • Review and synthesis of recent experimental data on HTLV-1-host cell interactions.
  • Development of a conceptual model for the HTLV-1 receptor complex.
  • Discussion of the functional significance of the proposed model.

Main Results:

  • Identification of GLUT1, NPN-1, and HSPGs as crucial components of the HTLV-1 entry pathway.
  • A proposed model detailing the coordinated function of these molecules in facilitating HTLV-1 binding and cellular entry.
  • Hypotheses regarding how this complex influences HTLV-1 infection dynamics.

Conclusions:

  • The HTLV-1 receptor complex is a multi-molecular entity involving GLUT1, NPN-1, and HSPGs.
  • Understanding this complex is vital for deciphering HTLV-1 pathogenesis.
  • The proposed model provides a framework for future research into HTLV-1 entry and therapeutic strategies.